Filing Details

Accession Number:
0000899243-20-035005
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-12-23 17:22:56
Reporting Period:
2020-12-22
Accepted Time:
2020-12-23 17:22:56
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1501134 Invitae Corp NVTA Services-Medical Laboratories (8071) 271701898
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1627766 E Sean George C/O Invitae Corporation
1400 16Th Street
San Francisco CA 94103
President & Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-12-22 236 $51.62 634,457 No 4 S Direct
Common Stock Disposition 2020-12-22 2,739 $52.95 631,718 No 4 S Direct
Common Stock Disposition 2020-12-22 700 $53.99 631,018 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales of common stock were effected pursuant to a Rule 10b-5 sales plan adopted by the reporting person on August 12, 2020.
  2. Represents a weighted average sale price. Actual sale prices ranged from $51.17 to $52.03 per share.
  3. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
  4. Represents a weighted average sale price. Actual sale prices ranged from $52.58 to $53.32 per share.
  5. Represents a weighted average sale price. Actual sale prices ranged from $53.73 to $54.30 per share.
  6. Includes an aggregate of 226,598 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested.